Local QP Support for Batch
Ensure Quality and Compliance from Manufacturing to Market While Navigating Regulatory Challenges with Our Expert QP Solutions
Ensure Quality and Compliance from Manufacturing to Market While Navigating Regulatory Challenges with Our Expert QP Solutions
We offer top-notch local Qualified Person (QP) support for batch release; ensuring pharmaceutical products meet regulatory standards with precision and expertise. Our services are tailored to your market’s specific needs, facilitating seamless and compliant batch release processes.
When a pharmaceutical product is released into a clinical trial or the market in the European Union, it must be certified by a Qualified Person (QP). This process, known as a QP release, occurs after the drug is released. Pharmaceutical products imported into the EU from outside the EU are also subject to QP certification and release. Zenovel offers QP services, and it is recommended to explore their range of activities and benefits.
The QP is responsible for ensuring that pharmaceutical products meet high standards and quality attributes, regardless of the manufacturing location. According to Article 48 of Directive 2001/83/EC, the QP must certify that each batch of pharmaceutical products complies with the established quality standards. Before a product is released to the market or used in clinical trials, the QP must verify that the product adheres to GMP guidelines and that all necessary documentation is authorized. Additionally, the QP ensures that the distribution of pharmaceutical products complies with both local regulations and international laws in the respective countries.
Extensive knowledge and experience in pharmaceutical quality and regulatory affairs.
In-depth understanding of local regulations and market
Dedicated to maintain highest quality standards compliance.
Ensure products are safe and effective.
Work closely with clients
Provide personalized support and solutions.
The European Union’s Good Manufacturing Practice (GMP) standards, as outlined in the Annex to the Guide to Good Manufacturing Practice for Medicinal Products, ensure the quality and safety of medicinal products, including those used in clinical trials. The Qualified Person (QP) plays a crucial role in batch certification, particularly for
In the intricate process of developing new pharmaceuticals, guaranteeing product safety, effectiveness, and adherence to global regulations is essential. Batch release testing acts as a pivotal quality assurance measure, confirming that medications comply with rigorous criteria before distribution. When combined with International Council for Harmonisation (ICH) standards, this testing framework
In the world of life sciences, quality isn’t just a benchmark—it’s the backbone of success. Three key pillars—Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP)—form the core framework that supports everything from product development to regulatory approval. These standards aren’t just industry buzzwords; they’re the
In the pharmaceutical industry, quality is paramount—and at Zenovel, we are deeply committed to delivering excellence in Quality Assurance (QA). Our focus is on ensuring that every medicine is developed, manufactured, and delivered with safety and reliability as top priorities. QA is embedded in every stage of the pharmaceutical lifecycle—from
The U.S. Food and Drug Administration (FDA) emphasize the importance of data integrity in pharmaceutical manufacturing, particularly under its Current Good Manufacturing Practices (CGMP) rules. However, issues like fake lab results and sloppy record-keeping persist, posing risks to patients and losing confidence in the system. Independent oversight is crucial to
In the rapidly evolving pharmaceutical industry, assuring product quality and customer safety is a need. This endeavour continues to be based on validation, a methodical procedure to verify that manufacturing procedures and equipment consistently deliver high-quality outcomes. A strong strategy to validation is required in 2025 due to the complexity
